This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-3506v1 69/8/3433    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, G. Articles by Sadar, M. D. Search for Related Content PubMed PubMed Citation Articles by Wang, G. Articles by Sadar, M. D.

Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression

¹ Genome Sciences Centre and ² Cancer Endocrinology, British Columbia Cancer Agency, ³ Department of Urology, University of Washington, and ⁴ Orthopaedic Surgery Vancouver General Hospital, Vancouver, British Columbia, Canada

Requests for reprints: Marianne D. Sadar, Genome Sciences Centre, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, CANADA, V5Z 1L3. Phone: 604-675-8157; Fax: 604-675-8178; E-mail: msadar{at}bcgsc.ca.

Key Words: bone metastases • hormonal progression • prostate cancer

Identification of gene expression signatures associated with metastases provides a tool to discern mechanisms and potential therapeutic targets and may lead toward a molecular classification system in pathology. Prostate cancer (CaP) frequently metastasizes to the bone to form osteoblastic lesions. Correlative clinical data and in vitro evidence have led to the hypothesis that osteoblast-derived factors promote hormonal progression of CaP cells. Here, the gene expression signature of CaP exposed to osteoblast-derived factors was identified. This signature included known androgen-regulated genes, oncogenes, tumor suppressors, and genes whose products are involved in apoptosis and cell cycle. A comparative functional genomic approach involved the application of this responsive gene expression signature to clinical samples of human CaP, melanomas, and oral cancers. Cluster analysis revealed that this gene expression signature had specificity for CaP and could resolve clinical specimens according to stage (benign, localized, and metastatic) and androgen sensitivity with an accuracy of 100% and 80%, respectively. Together, these results suggest that factors derived from osteoblasts induce a more advanced phenotype of CaP and promotes hormonal progression. [Cancer Res 2009;69(8):3433–42]